Interpace Diagnostics Group Inc (IDXG)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Interpace Diagnostics Group Inc (IDXG) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011106
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Interpace Diagnostics Group Inc (Interpace Diagnostics), formerly PDI Inc, is a developer of molecular diagnostics tests. The company offers PancraGen, a DNA based molecular test that aids in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its pathfinder platform; and ThyGenX and ThyraMIR, which collectively assess the risk of benign or malignant thyroid nodules, and minimizes unnecessary surgeries. It also provides diagnostic options for detecting genetic and other molecular alterations that are associated with gastrointestinal and endocrine cancers. The company’s labs are located in Pittsburgh, Pennsylvania, and New Haven, Connecticut. It serves its clients across the US. Interpace Diagnostics is headquartered in Parsippany, New Jersey, the US.

Interpace Diagnostics Group Inc (IDXG) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Interpace Diagnostics Group Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Interpace Diagnostics Group Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Interpace Diagnostics Group Inc, Medical Equipment, Deal Details 11
Asset Purchase 11
PDI Acquires MiRInform Thyroid and Pancreas Cancer Test Assets from Asuragen 11
Partnerships 13
Interpace Diagnostics Enters into Research Agreement with Viatar CTC Solutions 13
Equity Offering 14
Interpace Diagnostics Raises up to USD4 Million in Private Placement of Shares and Warrants 14
Interpace Diagnostics Raises USD4.3 Million in Private Placement of Shares 15
Interpace Diagnostics Raises USD2 Million in Private Placement of Shares and Warrants 16
Acquisition 17
PDI Acquires RedPath Integrated Pathology for USD23 Million 17
PDI Receives Option To Acquire Molecular Diagnostics Company 19
Interpace Diagnostics Group Inc – Key Competitors 20
Interpace Diagnostics Group Inc – Key Employees 21
Interpace Diagnostics Group Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Nov 18, 2016: Interpace Diagnostics Reports Third Quarter 2016 Results of Operations 23
Corporate Communications 24
Jul 28, 2016: PDI Appoints Keith St. John and Debra Hagberg to Infection Prevention Team 24
May 04, 2016: PDII Appoints New President, Matthew Gattuso 25
Legal and Regulatory 26
Jan 17, 2017: Interpace Diagnostics Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement 26
Product News 27
03/01/2016: Interpace Diagnostics Announces Agreement with America’s Choice Provider Network to Cover PancraGen for Pancreatic Cancer 27
03/01/2016: Interpace Diagnostics Announces Agreement with America’s Choice Provider Network to Cover ThyGenX Oncogene Panel for Thyroid Cancer 28
03/01/2016: Interpace Diagnostics Announces Agreement with America’s Choice Provider Network to Cover ThyraMIR Micro RNA Classifier for Thyroid Cancer 29
02/17/2016: Interpace Diagnostics Receives Medicare Coverage For Its ThyraMIR Micro RNA Gene Expression Classifer 30
01/28/2016: PancraGen Clinical Utility Study Published in Diagnostic Pathology 31
01/20/2016: Interpace Diagnostics Announces New Medicare Local Coverage Determination for Molecular Testing of Pancreatic Cysts 32
01/12/2016: Interpace Diagnostics’ New Molecular Test for Thyroid Nodules Now Available Through LabCorp 33
Other Significant Developments 34
Oct 13, 2016: PDI and SABIC Join Forces to Test Medical Device Plastics and to Help Improve Patient Protection from Infection 34
Jan 12, 2016: New PDI Visual Resource Highlights How Proper Disinfection Can Reduce Central Line-associated Bloodstream Infections 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Interpace Diagnostics Group Inc, Medical Equipment, Key Facts, 2016 2
Interpace Diagnostics Group Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Interpace Diagnostics Group Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Interpace Diagnostics Group Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Interpace Diagnostics Group Inc, Deals By Market, 2011 to YTD 2017 9
Interpace Diagnostics Group Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
PDI Acquires MiRInform Thyroid and Pancreas Cancer Test Assets from Asuragen 11
Interpace Diagnostics Enters into Research Agreement with Viatar CTC Solutions 13
Interpace Diagnostics Raises up to USD4 Million in Private Placement of Shares and Warrants 14
Interpace Diagnostics Raises USD4.3 Million in Private Placement of Shares 15
Interpace Diagnostics Raises USD2 Million in Private Placement of Shares and Warrants 16
PDI Acquires RedPath Integrated Pathology for USD23 Million 17
PDI Receives Option To Acquire Molecular Diagnostics Company 19
Interpace Diagnostics Group Inc, Key Competitors 20
Interpace Diagnostics Group Inc, Key Employees 21
Interpace Diagnostics Group Inc, Subsidiaries 22

★海外企業調査レポート[Interpace Diagnostics Group Inc (IDXG)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shionogi Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Shionogi Inc (Shionogi), a subsidiary of Shionogi & Co., Ltd, is a pharmaceutical company that develops and commercializes pharmaceutical products to address the unmet medical needs. The company offers a wide range of branded prescription products to treat chronic diseases. It markets produc …
  • Flexion Therapeutics Inc (FLXN):製薬・医療:M&Aディール及び事業提携情報
    Summary Flexion Therapeutics Inc (Flexion) develops and commercializes pain therapies. The company's pipeline is focused on indications that includes osteoarthritis knee pain (repeat administration), osteoarthritis knee synovial inflammation, bilateral knee osteoarthritis pain shoulder and hip osteo …
  • Costco Wholesale Corporation:企業の戦略・SWOT・財務分析
    Costco Wholesale Corporation - Strategy, SWOT and Corporate Finance Report Summary Costco Wholesale Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • 3i Infotech Ltd (3IINFOTECH):企業の財務・戦略的SWOT分析
    3i Infotech Ltd (3IINFOTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Metgasco Ltd (MEL):企業の財務・戦略的SWOT分析
    Summary Metgasco Ltd (Metgasco) is an oil and gas exploration company. The company that acquires, explores, produces, and develops oil and gas, petroleum and hydrocarbon assets. It holds interests in Clarence Moreton Basin, an exploration license located in northern New South Wales. Metgasco supplie …
  • Alibaba Group Holding Limited:企業のM&A・事業提携・投資動向
    Alibaba Group Holding Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Alibaba Group Holding Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Taisei Corporation:企業の戦略・SWOT・財務情報
    Taisei Corporation - Strategy, SWOT and Corporate Finance Report Summary Taisei Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Exactech Inc:医療機器:M&Aディール及び事業提携情報
    Summary Exactech Inc (Exactech) is a medical device company that offers orthopedic implant devices and related surgical instruments. The company’s products comprise hip implants, shoulder implants, knee implants, extremity implants, biologics and spine, and other products. It also provides biologic …
  • Galena Biopharma Inc (GALE)-医療機器分野:企業M&A・提携分析
    Summary Galena Biopharma Inc (Galena) is a biopharmaceutical company that develops and markets therapies for the treatment of unmet medical needs and advance care. The company's pipeline products comprise NeuVax, NeuVax Present, NeuVax Hercepti, NeuVax Vadis, GALE-401 and GALE-301 folate binding pro …
  • Celsense Inc-医療機器分野:企業M&A・提携分析
    Summary Celsense Inc (Celsense) is a biotechnology company that develops magnetic resonance imaging detection products. The company’s products include v-sense, cell sense and voxel tracker. Its v-sense product is used to detect a range of lesions and diseases where inflammation is a hallmark such as …
  • KAZ Minerals PLC:企業のM&A・事業提携・投資動向
    KAZ Minerals PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KAZ Minerals PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Olmuksan International Paper Ambalaj Sanayi ve Ticaret A.S.:企業の戦略・SWOT・財務情報
    Olmuksan International Paper Ambalaj Sanayi ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report Summary Olmuksan International Paper Ambalaj Sanayi ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers th …
  • Coupa Software Inc (COUP):企業の財務・戦略的SWOT分析
    Coupa Software Inc (COUP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • VION N.V.:企業のM&A・事業提携・投資動向
    VION N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's VION N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Edgewell Personal Care LLC (EPC):企業の財務・戦略的SWOT分析
    Edgewell Personal Care LLC (EPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Empire Energy Group Ltd (EEG):企業の財務・戦略的SWOT分析
    Summary Empire Energy Group Ltd (EEGL), formerly Imperial Corp Ltd is an oil and gas company that offers exploration and production programs. The company produces and develops oil and gas assets; and has interest in onshore oil and gas fields in Mid Con property and Appalachia property. It has onsho …
  • Osaka Gas Co Ltd (9532):電力:M&Aディール及び事業提携情報
    Summary Osaka Gas Co Ltd (OGCL) supplies natural gas to its customers in Kansai region, besides offering LPG, electricity and other energy-related products and services through affiliated enterprises. Its operations consist of domestic energy, environmental and non-energy, and international energy b …
  • Esco Technologies Inc (ESE):企業の財務・戦略的SWOT分析
    Esco Technologies Inc (ESE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Optus Inc:企業の戦略的SWOT分析
    Optus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • BASF Corp:企業の戦略的SWOT分析
    BASF Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆